Plain-English translation of NCT06973980 on ClinicalTrials.gov β Β· Source last updated Β· Translation generated Β· How we translate trials
This study doesn't follow the usual testing phases β it may be an observational study or a different type of research.
This trial is testing whether a 12-week exercise program called high-intensity interval training (HIIT) can help improve heart health, metabolism, and body composition in young adults who are overweight and not very active. The program involves short bursts of intense exercise followed by recovery periods. Researchers also want to see if this type of exercise affects a protein in your blood called FABP4, which is linked to heart disease and diabetes risk.
Many people who are overweight struggle with heart disease, diabetes, and metabolic problems. Recent research suggests that a specific protein called FABP4 may play a role in these conditions, and that exercise might help lower it. This study exists to see whether this type of intensive exercise program could be an effective way to improve these health problems.
You likely qualify ifβ¦
You likely don't qualify ifβ¦
If you are chosen for the exercise group, you will come in for a 12-week program where you do short bursts of very intense exercise (at 85β90% of your maximum heart rate) for 1 minute, followed by easier recovery periods. The program starts with 4 intense bursts per session in weeks 1β2, increases to 6 bursts in weeks 3β7, and goes up to 8 bursts in weeks 8β12. Each session includes a warm-up and cool-down. If you are in the control group, you will continue your normal activities with no special exercise program. Researchers will take blood samples and body measurements before, during, and after the 12 weeks.
AI-generated summary from trial data Β· Jun 16, 2026 Β· Not medical advice
Cyprus
Sponsor
Eastern Mediterranean University
Enrollment target
~28 participants
Started
March 2025
Primary completion
July 2025
This trial's estimated completion date has passed β the record may not be fully up to date.
Age range
20 Years β 35 Years
Last updated on clinicaltrials.gov in May 2025.
Reach out to the team running this trial. Response times vary β some teams are faster than others.
Central contact
YAΕAM DΔ°REL, MSc
Eastern Meditterean university
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first β no email needed to get started.